Long-term Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia

Hematology/Oncology Clinics of North America

Volumn 23, Issue 5, 2009, Pages 1065-1082

  Nathan, Paul C ^a,b   Wasilewski Masker, Karen ^c,d   Janzen, Laura A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c AFLAC   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukemia; Cancer survivor; Childhood; Cranial radiation; Late effects

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ASPARAGINASE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; EPIPODOPHYLLOTOXIN DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; OXAZAPHOSPHORINE DERIVATIVE; OXYGEN; PREDNISONE; VINCRISTINE; VITAMIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AVASCULAR NECROSIS; BLOOD CLOTTING DISORDER; BONE DENSITY; BONE NECROSIS; BRAIN HEMORRHAGE; CANCER SURVIVOR; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM DISEASE; CEREBROVASCULAR ACCIDENT; CHILDHOOD LEUKEMIA; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG MEGADOSE; FRACTURE; GONADAL DISEASE; GROWTH HORMONE DEFICIENCY; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; LEUKEMIA RELAPSE; LONGITUDINAL STUDY; MEDICAL CARE; METABOLIC DISORDER; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; MYELODYSPLASTIC SYNDROME; NERVE CONDUCTION; NEUROENDOCRINE DISEASE; NEUROLOGIC DISEASE; NEUROTOXICITY; OBESITY; OSTEOPENIA; PATIENT CARE PLANNING; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION HAZARD; REVIEW; SIDE EFFECT; THROMBOPHILIA; TREATMENT OUTCOME; WEIGHT BEARING;

CHILD; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349741017     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.07.003     Document Type: Review

References (137)

1. In: Ries L.A.G., Smith M.A., Gurney J.G., et al. (Eds). Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 (1999), National Cancer Institute, SEER Program, (NIH publication no. 99-4649). Bethesda (MD)
2. Moghrabi A., Levy D.E., Asselin B., et al. Results of the Dana Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109 3 (2007) 896-904
3. Schrappe M., Reiter A., Ludwig W.D., et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian Swiss ALL-BFM study group. Blood 95 11 (2000) 3310-3322
4. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 (2006) 1572-1582
5. Geenen M.M., Cardous-Ubbink M.C., Kremer L.C.M., et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297 24 (2007) 2705-2715
6. Langeveld N.E., Ubbink M.C., Last B.F., et al. Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands. Psychooncology 12 3 (2003) 213-225
7. Mody R., Li S., Dover D.C., et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Blood 111 12 (2008) 5515-5523
8. Spiegler B.J., Kennedy K., Maze R., et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 24 24 (2006) 3858-3864
9. Jankovic M., Brouwers P., Valsecchi M.G., et al. Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International study group on psychosocial aspects of childhood cancer. Lancet 344 8917 (1994) 224-227
10. Howard S.C., and Pui C.H. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 16 4 (2002) 225-243
11. Nesbit Jr. M.E., Sather H.N., Robison L.L., et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group. Lancet 1 8218 (1981) 461-466
12. Bleyer W.A., and Poplack D. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 12 2 (1985) 131-148
13. Pui C.H., Robison L.L., and Look A.T. Acute lymphoblastic leukaemia. Lancet 371 9617 (2008) 1030-1043
14. Krull K.R., Brouwers P., Jain N., et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 152 1 (2008) 101-105
15. Blanco J.G., Leisenring W.M., Gonzalez-Covarrubias V.M., et al. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 112 12 (2008) 2789-2795
16. Wu E., Robison L.L., Jenney M.E., et al. Assessment of health-related quality of life of adolescent cancer patients using the Minneapolis-Manchester quality of life adolescent questionnaire. Pediatr Blood Cancer 48 7 (2007) 678-686
17. Cousens P., Waters B., Said J., et al. Cognitive effects of cranial irradiation in leukaemia: a survey and meta-analysis. J Child Psychol Psychiatry 29 6 (1988) 839-852
18. Rubenstein C.L., Varni J.W., and Katz E.R. Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis. J Dev Behav Pediatr 11 6 (1990) 301-305
19. Kato M., Azuma E., Ido M., et al. Ten-year survey of the intellectual deficits in children with acute lymphoblastic leukemia receiving chemoimmunotherapy. Med Pediatr Oncol 21 6 (1993) 435-440
20. Bleyer W.A., Fallavollita J., Robison L., et al. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group. Pediatr Hematol Oncol 7 4 (1990) 329-338
21. Waber D.P., Urion D.K., Tarbell N.J., et al. Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent. Dev Med Child Neurol 32 3 (1990) 238-248
22. Schatz J., Kramer J.H., Ablin A., et al. Processing speed, working memory and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 14 2 (2000) 189-200
23. Fletcher J.M., and Copeland D.R. Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol 10 4 (1988) 495-537
24. Smibert E., Anderson V., Godber T., et al. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia. Br J Cancer 73 6 (1996) 825-830
25. Anderson V., Smibert E., Ekert H., et al. Intellectual, educational, and behavioural sequelae after cranial irradiation and chemotherapy. Arch Dis Child 70 6 (1994) 476-483
26. Mitby P.A., Robison L.L., Whitton J.A., et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 97 4 (2003) 1115-1126
27. Mulhern R.K., Fairclough D., and Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol 9 8 (1991) 1348-1356
28. Copeland D.R., Moore III B.D., Francis D.J., et al. Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. J Clin Oncol 14 10 (1996) 2826-2835
29. Ochs J., Mulhern R., Fairclough D., et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 9 1 (1991) 145-151
30. Peterson C.C., Johnson C.E., Ramirez L.Y., et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 51 1 (2008) 99-104
31. Silverman L.B., McLean T.W., Gelber R.D., et al. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana Farber Cancer Institute consortium. Cancer 80 12 (1997) 2285-2295
32. Mulhern R.K., Ochs J., Fairclough D., et al. Intellectual and academic achievement status after CNS relapse: a retrospective analysis of 40 children treated for acute lymphoblastic leukemia. J Clin Oncol 5 6 (1987) 933-940
33. Nathan P.C., Patel S.K., Dilley K., et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med 161 8 (2007) 798-806
34. Butler R.W. Attentional processes and their remediation in childhood cancer. Med Pediatr Oncol Suppl 1 (1998) 75-78
35. Butler R.W., and Copeland D.R. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 8 1 (2002) 115-124
36. Thompson S.J., Leigh L., Christensen R., et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 19 6 (2001) 1802-1808
37. Mulhern R.K., Khan R.B., Kaplan S., et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 22 23 (2004) 4795-4803
38. Hogan A.M., Kirkham F.J., and Isaacs E.B. Intelligence after stroke in childhood: review of the literature and suggestions for future research. J Child Neurol 15 5 (2000) 325-332
39. Ott N., Ramsay N.K., Priest J.R., et al. Sequelae of thrombotic or hemorrhagic complications following l-asparaginase therapy for childhood lymphoblastic leukemia. Am J Pediatr Hematol Oncol 10 3 (1988) 191-195
40. Bowers D.C., Liu Y., Leisenring W., et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the childhood cancer survivor study. J Clin Oncol 24 33 (2006) 5277-5282
41. Chauvenet A.R., Shashi V., Selsky C., et al. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 25 4 (2003) 316-320
42. Trobaugh-Lotrario A.D., Smith A.A., and Odom L.F. Vincristine neurotoxicity in the presence of hereditary neuropathy. Med Pediatr Oncol 40 1 (2003) 39-43
43. Lehtinen S.S., Huuskonen U.E., Harila-Saari A.H., et al. Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer 94 9 (2002) 2466-2473
44. Wright M.J., Halton J.M., Martin R.F., et al. Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 31 2 (1998) 86-90
45. Hockenberry M., Krull K., Moore K., et al. Longitudinal evaluation of fine motor skills in children with leukemia. J Pediatr Hematol Oncol 29 8 (2007) 535-539
46. Nand S., Messmore Jr. H.L., Patel R., et al. Neurotoxicity associated with systemic high-dose cytosine arabinoside. J Clin Oncol 4 4 (1986) 571-575
47. Mills J., Bonner A., and Francis K. The development of constructivist grounded theory. International Journal of Qualitative Methods 5 1 (2006) 25-35
48. DeGroot L.J. Effects of irradiation on the thyroid gland. Endocrinol Metab Clin North Am 22 3 (1993) 607-615
49. Sklar C.A., and Constine L.S. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31 5 (1995) 1113-1121
50. Haddy T.B., Mosher R.B., Nunez S.B., et al. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Pediatr Blood Cancer 46 2 (2006) 258-261
51. Chow E.J., Friedman D.L., Yasui Y., et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Pediatr 150 4 (2007) 370-375 75 e1
52. Chemaitilly W., and Sklar C.A. Endocrine complications of hematopoietic stem cell transplantation. Endocrinol Metab Clin North Am 36 4 (2007) 983-998 ix
53. Mertens A.C., Yasui Y., Liu Y., et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 95 11 (2002) 2431-2441
54. Ergun-Longmire B., Mertens A.C., Mitby P., et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91 9 (2006) 3494-3498
55. Leiper A.D., Stanhope R., Kitching P., et al. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child 62 11 (1987) 1107-1112
56. Ogilvy-Stuart A.L., Clayton P.E., and Shalet S.M. Cranial irradiation and early puberty. J Clin Endocrinol Metab 78 6 (1994) 1282-1286
57. Quigley C., Cowell C., Jimenez M., et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med 321 3 (1989) 143-151
58. Chow E.J., Friedman D.L., Yasui Y., et al. Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Pediatr Blood Cancer 50 4 (2008) 854-858
59. Mills J.L., Fears T.R., Robison L.L., et al. Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr 131 4 (1997) 598-602
60. Reilly J.J., Ventham J.C., Newell J., et al. Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia. Int J Obes Relat Metab Disord 24 11 (2000) 1537-1541
61. Sklar C.A., Mertens A.C., Walter A., et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 35 2 (2000) 91-95
62. Garmey E.G., Liu Q., Sklar C.A., et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 26 28 (2008) 4639-4645
63. Mayer E.I., Reuter M., Dopfer R.E., et al. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 53 4 (2000) 193-199
64. Van Dongen-Melman J.E., Hokken-Koelega A.C., Hahlen K., et al. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 38 1 (1995) 86-90
65. Warner J.T., Evans W.D., Webb D.K., et al. Body composition of long-term survivors of acute lymphoblastic leukaemia. Med Pediatr Oncol 38 3 (2002) 165-172
66. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol 21 7 (2003) 1359-1365
67. Ross J.A., Oeffinger K.C., Davies S.M., et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 22 17 (2004) 3558-3562
68. Nathan P.C., Jovcevska V., Ness K.K., et al. The prevalence of overweight and obesity in pediatric survivors of cancer. J Pediatr 149 4 (2006) 518-525 e2
69. Reilly J.J., Brougham M., Montgomery C., et al. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 86 8 (2001) 3742-3745
70. Jansen H., Postma A., Stolk R.P., et al. Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity?. Support Care Cancer 17 1 (2009) 103-106
71. van Brussel M., Takken T., Lucia A., et al. Is physical fitness decreased in survivors of childhood leukemia? A systematic review. Leukemia 19 1 (2005) 13-17
72. Kaste S.C., Jones-Wallace D., Rose S.R., et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 15 5 (2001) 728-734
73. Kadan-Lottick N.S., Dinu I., Wasilewski-Masker K., et al. Osteonecrosis in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 26 18 (2008) 3038-3045
74. Reilly J.J., Kelly A., Ness P., et al. Premature adiposity rebound in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 86 6 (2001) 2775-2778
75. Reilly J.J., Ventham J.C., Ralston J.M., et al. Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia. Pediatr Res 44 4 (1998) 557-562
76. Warner J.T., Bell W., Webb D.K., et al. Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatr Res 43 5 (1998) 607-613
77. Aznar S., Webster A.L., San Juan A.F., et al. Physical activity during treatment in children with leukemia: a pilot study. Appl Physiol Nutr Metab 31 4 (2006) 407-413
78. Jago R., Baranowski T., Baranowski J.C., et al. BMI from 3-6 y of age is predicted by TV viewing and physical activity, not diet. Int J Obes (Lond) 29 6 (2005) 557-564
79. Oeffinger K.C., Buchanan G.R., Eshelman D.A., et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 23 7 (2001) 424-430
80. Talvensaari K.K., Lanning M., Tapanainen P., et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 81 8 (1996) 3051-3055
81. Taskinen M., Saarinen-Pihkala U.M., Hovi L., et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356 (2000) 993-997
82. Cook S. The metabolic syndrome: antecedent of adult cardiovascular disease in pediatrics. J Pediatr 145 (2004) 427-430
83. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
84. Lakka H.-M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 21 (2002) 2709-2716
85. Link K., Moell C., Garwicz S., et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 89 10 (2004) 5003-5012
86. Gurney J.G., Ness K.K., Sibley S.D., et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107 6 (2006) 1303-1312
87. Kuk J.L., Katzmarzyk P.T., Nichaman M.Z., et al. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 14 2 (2006) 336-341
88. Janiszewski P.M., Oeffinger K.C., Church T.S., et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab 92 10 (2007) 3816-3821
89. Halton J.M., Atkinson S.A., and Barr R.D. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia. Int J Cancer Suppl 11 (1998) 81-84
90. Baillargeon J., Langevin A.M., Lewis M., et al. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia. Cancer 103 8 (2005) 1725-1729
91. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 73 5 (2006) 500-507
92. Mattano L. The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting. Pediatr Transplant 7 Suppl 3 (2003) 71-75
93. Hanada T., Horigome Y., Inudoh M., et al. Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia during l-asparaginase therapy. Eur J Pediatr 149 3 (1989) 162-171
94. Watson R.M., Roach N.A., and Dalinka M.K. Avascular necrosis and bone marrow edema syndrome. Radiol Clin North Am 42 1 (2004) 207-219
95. Arico M., Boccalatte M.F., Silvestri D., et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88 7 (2003) 747-753
96. Burger B., Beier R., Zimmermann M., et al. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) - experiences from trial ALL-BFM 95. Pediatr Blood Cancer 44 3 (2005) 220-225
97. Mattano Jr. L.A., Sather H.N., Trigg M.E., et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 18 18 (2000) 3262-3272
98. Strauss A.J., Su J.T., Dalton V.M., et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 19 12 (2001) 3066-3072
99. Enright H., Haake R., and Weisdorf D. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 89 6 (1990) 733-738
100. Koo K.H., and Kim R. Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br 77 6 (1995) 875-880
101. Ojala A.E., Paakko E., Lanning F.P., et al. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol 32 1 (1999) 11-17
102. Ribeiro R.C., Fletcher B.D., Kennedy W., et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 15 6 (2001) 891-897
103. Jones L.C., and Hungerford D.S. Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol 16 4 (2004) 443-449
104. Hochberg Z. Mechanisms of steroid impairment of growth. Horm Res 58 Suppl 1 (2002) 33-38
105. Leonard M.B. Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques. Med Pediatr Oncol 41 3 (2003) 198-207
106. Pfeilschifter J., and Diel I.J. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 18 7 (2000) 1570-1593
107. Davies J.H., Evans B.A., Jenney M.E., et al. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 63 1 (2005) 1-9
108. Halton J.M., Atkinson S.A., Fraher L., et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11 11 (1996) 1774-1783
109. Hoorweg-Nijman J.J., Kardos G., Roos J.C., et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol (Oxf) 50 2 (1999) 237-244
110. Kaste S.C., Rai S.N., Fleming K., et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 46 1 (2006) 77-87
111. Warner J.T., Evans W.D., Webb D.K., et al. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res 45 4 Pt 1 (1999) 544-551
112. Henderson R.C., and Madsen C.D. Bone mineral content and body composition in children and young adults with cystic fibrosis. Pediatr Pulmonol 27 2 (1999) 80-84
113. Hesseling P.B., Hough S.F., Nel E.D., et al. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl 11 (1998) 44-47
114. Leslie W.D., Adler R.A., El-Hajj Fuleihan G., et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J Clin Densitom 9 1 (2006) 22-30
115. Wasilewski-Masker K., Kaste S.C., Hudson M.M., et al. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 121 3 (2008) e705-e713
116. Adams M.J., Lipshultz S.E., Schwartz C., et al. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13 3 (2003) 346-356
117. Lipshultz S.E., Lipsitz S.R., Sallan S.E., et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23 12 (2005) 2629-2636
118. Nysom K., Holm K., Lipsitz S.R., et al. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol 16 2 (1998) 545-550
119. Oeffinger K.C. Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?. Pediatr Blood Cancer 50 2 Suppl (2008) 462-467 [discussion: 468]
120. Hijiya N., Hudson M.M., Lensing S., et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297 11 (2007) 1207-1215
121. Loning L., Zimmermann M., Reiter A., et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95 9 (2000) 2770-2775
122. Bhatia S., Sather H.N., Pabustan O.B., et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99 12 (2002) 4257-4264
123. Borgmann A., Zinn C., Hartmann R., et al. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer 44 2 (2008) 257-268
124. Neglia J.P., Meadows A.T., Robison L.L., et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325 19 (1991) 1330-1336
125. Meistrich M.L., Wilson G., Brown B.W., et al. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 70 11 (1992) 2703-2712
126. Ridola V., Fawaz O., Aubier F., et al. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer 45 5 (2009) 814-818
127. Hamre M.R., Robison L.L., Nesbit M.E., et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 5 11 (1987) 1759-1765
128. Howell S., and Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 27 4 (1998) 927-943
129. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 34 (2005) 25-27
130. Chiarelli A.M., Marrett L.D., and Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 150 3 (1999) 245-254
131. Hewitt M., Weiner S.L., and Simone J.V. Childhood cancer survivorship: improving care and quality of life (2003), The National Academies Press, Washington, DC
132. Hewitt M., Greenfield S., and Stovall E. From cancer patient to cancer survivor: lost in transition (2005), National Academies Press, Washington, DC
133. In: Hudson M., Landier W., Eshelman D., et al. (Eds). Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (2006), Children's Oncology Group, Acadia (CA)
134. In: Skinner R., Wallace W.H.B., and Levitt G.A. (Eds). Therapy based long term follow up: practice statement. 2nd edition (2005), United Kingdom Children's Cancer Study Group
135. Long term follow up of survivors of childhood cancer: a national clinical guideline. Scottish Collegiate Guidelines Network. Available at:. http://www.sign.ac.uk/pdf/sign76.pdf Accessed March 11, 2009
136. Landier W., Wallace W.H., and Hudson M.M. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatr Blood Cancer 46 2 (2006) 149-158
137. Freyer D.R., and Brugieres L. Adolescent and young adult oncology: transition of care. Pediatr Blood Cancer 50 5 Suppl (2008) 1116-1119